Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
808.00    -10.00 (-1.22%)
Bid:
811.00
Ask:
813.00
Spread: 2.00 (0.247%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Completion of Acquisition

2 Jun 2014 07:00

RNS Number : 5566I
Savills PLC
02 June 2014
 

02 June 2014

 

 

SAVILLS COMPLETES STUDLEY ACQUISITION

 

International real estate advisor Savills today announces the completion, effective 30 May 2014, of its acquisition of 100% of Studley, Inc. the leading US independent commercial real estate services firm specialising in tenant representation.

 

Savills also announces that on 29 May 2014, Studley Inc. agreed to sell its 49.06% interest in AOS Partners Holdings SAS ("AOS Studley"), the French EMEA-focussed project management business, to the founding shareholder of AOS Studley. This follows the announcement on 1 May that the AOS Studley interest would be held as an asset for sale. The sale, which is subject to customary conditions, is due to complete this summer.

 

As announced on 1 May 2014, the consideration payable by Savills for Studley Inc. is up to US$260 million (up to US$246 million net of the proceeds, which will be retained by Savills, from the agreed sale of Studley Inc's 49.06% interest in AOS Studley) as follows:

 

· initial consideration of US$130 million. Approximately half of the initial consideration is in the form of 5.8 million new ordinary Savills shares (with a value of US$62.2 million, at the volume weighted average price of 635p per share over the 20 trading days before the 1 May 2014 announcement) which will be issued to vendor shareholders in three equal annual instalments commencing on the first anniversary of completion. The balance of the initial consideration, of US$67.8 million was paid in cash on completion; and

 

· promissory notes with a face value of up to US$130 million, with US$60 million of such notes payable on the first anniversary of completion and up to US$70 million on the third anniversary of completion. The majority of the noteholders will be vendor shareholders who will be paid the face value of the third anniversary notes only if they remain actively engaged in the business at the payment date.

 

The newly combined US business will be re-branded Savills Studley

 

- ends -

 

For further information please contact:

 

Savills Tel: +44 20 7409 8934

Jeremy Helsby, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications Tel: +44 20 7353 4200

Peter Hewer

.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQDGGDLRSGBGSB
Date   Source Headline
1st Jun 202611:29 amRNSTotal Voting Rights
22nd May 202610:09 amRNSDirector/PDMR Shareholding
14th May 202612:41 pmRNSResult of AGM
13th May 20264:16 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Statement
12th May 20263:41 pmRNSDirector/PDMR Shareholding
7th May 20263:39 pmRNSDirector Declaration
29th Apr 20263:04 pmRNSReplacement - Director/PDMR Shareholding
29th Apr 20261:23 pmRNSDirector/PDMR Shareholding
28th Apr 20261:58 pmRNSDirector/PDMR Shareholding
13th Apr 20265:24 pmRNSHolding(s) in Company
13th Apr 20262:10 pmRNSDirector/PDMR Shareholding
7th Apr 20264:03 pmRNSAnnual Report and AGM Notice
1st Apr 202610:00 amRNSTotal Voting Rights
31st Mar 202612:55 pmRNSDirector/PDMR Shareholding
26th Mar 20268:57 amRNSDirector/PDMR Shareholding
24th Mar 202611:02 amRNSDirector/PDMR Shareholding
23rd Mar 20269:27 amRNSDirector/PDMR Shareholding
18th Mar 20263:47 pmRNSDirector/PDMR Shareholding
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
13th Mar 20261:34 pmRNSDirector/PDMR Shareholding
13th Mar 20261:32 pmRNSDirector/PDMR Shareholding
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:08 amRNSFinal Results
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
5th Mar 20265:00 pmRNSHolding(s) in Company
2nd Mar 20269:11 amRNSTotal Voting Rights
25th Feb 202611:14 amRNSHolding(s) in Company
11th Feb 20264:07 pmRNSDirector/PDMR Shareholding
4th Feb 20265:29 pmRNSHolding(s) in Company
2nd Feb 20265:32 pmRNSTotal Voting Rights
19th Jan 20268:30 amRNSDirectorship change
15th Jan 20267:00 amRNSYear End Trading Update
13th Jan 20265:40 pmRNSDirector/PDMR Shareholding
13th Jan 202612:59 pmRNSHolding(s) in Company
2nd Jan 20263:00 pmRNSTotal Voting Rights
11th Dec 20252:00 pmRNSDirector/PDMR Shareholding
1st Dec 20259:49 amRNSTotal Voting Rights
11th Nov 20254:58 pmRNSDirector/PDMR Shareholding
3rd Nov 202512:32 pmRNSTotal Voting Rights
13th Oct 20251:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.